Bengaluru-based BacAlt Biosciences raised $2M in pre-seed funding from Avaana Capital and Lubrizol InnoVentures. Founded in 2024 by Shruti Kutmutia and Pranav Nair, the biotech startup makes biopolymers from post-harvest waste to reduce petrochemical use. The funds will expand R&D and production. Serving home care, personal care, and pharma sectors, BacAlt aims to position India as a bio-manufacturing hub within a $300B bioeconomy by 2030.
Trending
- Fraganote Secures $3 Million Series A to Propel D2C Growth and Portfolio Expansion
- Fraganote Secures $3 Million Series A to Propel D2C Growth and Portfolio Expansion
- Amazon Prime Music in India to Introduce Ads, Remove Offline Downloads From July 2026
- Amazon Prime Music in India to Introduce Ads, Remove Offline Downloads From July 2026
- Acko Taps Top Banks for H1 2027 IPO Target
- Fairdeal.Market Secures US$15M to Scale B2B Quick Commerce Across India
- India’s Startup IPO Surge: 48+ Listings Set to Unlock INR 50,000 Cr in 2026
- Indian Startup IPO Surge Expected by 2026 Amid Market Reset


